Atlas Trials

A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection

Clinical trial NCT00002249 · COMPLETED

Trial details

NCT number
NCT00002249
Sponsor
R W Johnson Pharmaceutical Research Institute
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HIV Infections

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.